| 标题 |
Cost-effectiveness analysis of targeted-release formulation of budesonide (Tarpeyo) in conjunction with optimized renin-angiotensin system inhibitor (RASi) therapy relative to optimized RASi therapy alone for adults with primary immunoglobulin A nephropathy in the United States |
| 网址 | |
| DOI |
10.18553/jmcp.2025.31.5.499
doi
|
| 其它 |
期刊:Journal of Managed Care & Specialty Pharmacy 作者:Mohsen Yaghoubi; Heng Jiang; Roman Casciano; Christopher Ngai; Mit Patel 出版日期:2025-05-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)